2011;36(5)(Diabetes suppl):10-15
Read our recent blog post written by Dara Katcher Levy and Sarah Wicks where they provide some high level thoughts on the CDER ad/pro letters released yesterday
After administration of the 8-week clinical therapy, all detected acyl-carnitines had significant differences between the pre- and post-treatment groups with FDR q 1.0 with the OPLS-DA selection
[18] [19] At supplement amounts of 26 grams (0.0710.212 oz) per day over a month, there was no consistent evidence that carnitine affected exercise or physical performance on moderate-intensity exercises, whereas on high-intensity exercises results were mixed
For the L-GSH supplementation group, the levels of reduced form of GSH remained relatively the same and were not significantly different between pre- and post- L-GSH supplementation in plasma ( Figure 4F ) and PBMCs ( Figure 4G )
You see, the liver processes everything from medications to environmental exposures to byproducts of normal digestion